Nivolumab plus cabozantinib superior to sunitinib in renal cell carcinoma

Media coverage

• Title	Nivolumab plus cabozantinib superior to sunitinib in renal cell carcinoma
  Media name/outlet	MIMS
  Country/Territory	Singapore
  Date	3/03/23
  URL	ct.moreover.com/?a=50150241154&p=1gw&v=1&x=N07vObWcDMlQQwlfTFfpBw
  Persons	Mauricio Burotto

• Title	First-line nivolumab plus cabozantinib superior to sunitinib in advanced renal cell carcinoma
  Media name/outlet	MIMS
  Country/Territory	Singapore
  Date	3/03/23
  URL	ct.moreover.com/?a=50150397742&p=1gw&v=1&x=TfFXFE0afCSm8S0HyKvZVw
  Persons	Mauricio Burotto